Phase 2 study of pembrolizumab in patients with advanced rare cancers (vol 8, e000347, 2020)
Aung Naing,Funda Meric-Bernstam,Bettzy Stephen,Daniel D. Karp,Joud Hajjar,Jordi Rodon Ahnert,Sarina A. Piha-Paul,Rivka R. Colen,Camilo Jimenez,Kanwal P. Raghav,Renata Ferrarotto,Shi-Ming Tu,Matthew Campbell,Linghua Wang,Sarjeel H. Sabir,Coya Tapia,Chantale Bernatchez,Michael Frumovitz,Nizar Tannir,Vinod Ravi,Saria Khan,Jeane M. Painter,Abulrahman Abonofal,Jing Gong,Anas Alshawa,Lacey M. McQuinn,Mingxuan Xu,Sara Ahmed,Vivek Subbiah,David S. Hong,Shubham Pant,Timothy A. Yap,Apostolia M. Tsimberidou,Ecaterina E. Ileana Dumbrava,Filip Janku,Siqing Fu, Richard M. Simon,Kenneth R. Hess,Gauri R. Varadhachary,Mouhammed Amir Habra JOURNAL FOR IMMUNOTHERAPY OF CANCER(2020)
AI 理解论文
溯源树
样例